Pten is essential for embryonic development and tumour suppression

Nature Genetics

Volumn 19, Issue 4, 1998, Pages 348-355

  Di Cristofano, Antonio ^a   Pesce, Barbara ^a   Cordon Cardo, Carlos ^a   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE;

ANIMAL CELL; ARTICLE; CANCER; CANCER SUSCEPTIBILITY; EMBRYO DEVELOPMENT; GENE MUTATION; LETHALITY; MOUSE; NONHUMAN; ONTOGENY; PATHOGENESIS; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELLS, CULTURED; COLONIC NEOPLASMS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GENES, LETHAL; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; MALE; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; STEM CELLS; TERATOCARCINOMA; TESTICULAR NEOPLASMS; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MAMMALIA;

EID: 0031870959     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/1235     Document Type: Article

References (44)

1. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997).
2. Steck, P.A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Mature Genet. 15, 356-362 (1997).
3. Guldberg, P. et al. Disruption of the MMAC11PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57, 3660-3663 (1997).
4. Risinger, J.I., Hayes, A.K., Berchuck, A. & Barren, J.C. PTENIMMAC1 mutations in endometrial cancers. Cancer Res. 57, 4736-4738 (1997).
5. Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64-67 (1997).
6. Marsh, D.J. et al. Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosom. Cancer 21, 61-69 (1998).
7. Nelen, M.R. et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 6, 1383-1387 (1997).
8. Bannayan, G.A. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome.-Arch. Pathol. 92, 1-5 (1971).
9. Zonana, J., Rimoin, D.L. & Davis, D.C. Macrocephaly with multiple lipomas and hemangiomas. J. Paediatr. 89, 600-603 (1976).
10. Eng, C. et al. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J. Med. Genet. 31, 458-461 (1994).
11. Gorlin, R.J., Cohen, M.M., Jr., Condon, L.M. & Burke, B.A. Bannayan-Riley-Ruvalcaba syndrome. Am. J. Med. Genet. 44, 307-314 (1992).
12. Myers, M.P. & Tonks, N.K. PTEN: sometimes taking it off can be better than putting it on. Am. J. Hum. Genet. 61, 1234-1238 (1997).
13. Barford, D., Jia, Z. & Tonks, N.K. Protein tyrosine phosphatases take off. Nature Struct. Biol. 2, 1043-1053 (1995).
14. Furnari, F.B., Lin, H., Huang, H.S. & Cavenee, W.K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl Acad. Sci. USA 94, 12479-12484 (1997).
15. Akiyama, S.K., Olden, K. & Yamada, K.M. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14, 173-189 (1995).
16. Tamura, M. et al. Inhibition of cell migration, spreading and focal adhesions by tumour suppressor PTEN. Science 280, 1614-1617 (1998).
17. Thomas, K.R. & Capecchi, M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512 (1987).
18. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153-1163 (1991).
19. Padberg, G.W., Schot, J.D., Vielvoye, G.J., Bots, G.T. & de Beer, F.C. Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann. Neurol. 29, 517-523 (1991).
20. Gerlach, C., Golding, M., Larue, L., Alison, M.R. & Gerdes, J. Ki-67 immunoexpression is a robust marker of proliferative cells in the rat. Lab. Invest. 77, 697-698 (1997).
21. Doetschman, T.C., Eistetter, H., Katz, M., Schmidt, W. & Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryo!. Exp. Morphol. 87, 27-45 (1985).
22. Robertson, E.J. Teratocarcinomas and embryonic stem cells: a practical approach. (IRL, Oxford, U.K., 1987).
23. Keller, G., Kennedy, M., Papayannopoulou, T. & Wiles, M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13, 473-486 (1993).
24. Coucouvanis, E. & Martin, G.R. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell 83, 279-287 (1995).
25. Rosti, V. et al. Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J. Clin. Invest. 100, 1028-1036 (1997).
26. Elefanty, A.G., Robb, L., Birner, R. & Begley, C.G. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood 90, 1435-1447 (1997).
27. Winnier, G., Blessing, M., Labosky, P.A. & Hogan, B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9, 2105-2116 (1995).
28. Collignon, J. et al. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 122, 509-520 (1996).
29. Roach, S., Schmid, W. & Pera, M.F. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation. Exp. Cell. Res. 215, 189-198 (1994).
30. Chen, W.S. et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 8, 2466-2477 (1994).
31. Sirard, C. et al. The tumour suppressor gene 5mad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12, 107-119 (1998).
32. Edelhoff, S. et al. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MX11 to human chromosome 10 and mouse chromosome 19. Oncogene 9, 665-668 (1994).
33. Shapiro, D.N. et al. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics 23, 282-285 (1994).
34. Wechsler, D.S. et al. Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q2S. Genormcs 21, 669-672 (1994).
35. Marsh, D.J. et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7, 507-515 (1998).
36. Kinzler, K.W. & Vogelstein, B. Landscaping the cancer terrain. Science 280, 1036-1037 (1998).
37. Whang, Y.E. et al. Inactivation of the tumour suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl Acad. Sci. USA 95, 5246-5250 (1998).
38. Schreiber-Agus, N. et al. Role of Mxi1 in aging organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487 (1998).
39. Eagle, L.R. et al. Mutation of the MXI1 gene in prostate cancer. Nature Genet. 9, 249-255 (1995).
40. Howe, J.R. et al. Mutations in the SMAD41DPC4 gene in juvenile polyposis. Science 280, 1086-1088 (1998).
41. Takaku, K. et al. Intestinal tumour igenesis in compound mutant mice of both Dpc4 (Smad4) and Apc gene. Cell 92, 645-656 (1998).
42. Serrano, M. et al. Role of the INK4a locus in tumour suppression and cell mortality. Cell 85, 27-37 (1996).
43. Suzuki, H. et al. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res. 58, 204-209 (1998).
44. Wiles, M.V. Embryonic stem cell differentiation in vitro. Methods Enzymol. 225, 900-918 (1993).